In the biopharmaceutical industry, process data is used in multiple ways throughout process development and the different production phases. However, equipment used are often connected only by process; that is, the bioprocess material passing between each of them. Often this connection is discontinuous, meaning equipment is controlled on an instrument-level, resulting in islands of automation. This white paper outlines how connectivity and comprehensive automation solution can facilitate technology transfer and scaling from process development to final manufacturing scale. Appropriate automation solutions also help maximize manufacturing efficiency and facility utilization.